Montelukast Actavis

Montelukast Actavis

montelukast

Manufacturer:

Teva

Distributor:

Zuellig
Concise Prescribing Info
Contents
Montelukast
Indications/Uses
Treatment of asthma as add-on therapy in patients w/ mild to moderate persistent asthma inadequately controlled on inhaled corticosteroids & short-acting β-agonists. Prophylaxis for exercise-induced bronchoconstriction. Chewtab Alternative treatment in patients w/ mild persistent asthma who do not have recent history of serious asthma attacks. FC tab Symptomatic relief of seasonal allergic rhinitis in patients ≥15 yr.
Dosage/Direction for Use
Chewtab Childn 6-14 yr 5 mg daily. 2-5 yr 4 mg daily. FC tab Adult & childn ≥15 yr 10 mg once daily. Doses to be taken in the evening.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity.
Special Precautions
Acute asthma attacks. Not to be abruptly substituted for inhaled or oral corticosteroids. Churg-Strauss syndrome. Phenylketonuria. Galactose intolerance, Lapp lactase deficiency, glucose-galactose malabsorption. May affect ability to drive or operate machinery. Pregnancy & lactation.
Adverse Reactions
Headache, abdominal pain, thirst.
Drug Interactions
Decreased conc w/ CYP3A4 inducers eg, phenytoin, phenobarb, rifampicin.
ATC Classification
R03DC03 - montelukast ; Belongs to the class of leukotriene receptor antagonists. Used in the systemic treatment of obstructive airway diseases.
Presentation/Packing
Form
Montelukast Actavis chewable tab 4 mg
Packing/Price
28's
Form
Montelukast Actavis chewable tab 5 mg
Packing/Price
28's
Form
Montelukast Actavis FC tab 10 mg
Packing/Price
28's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in